Related Experiment Video

Updated: Jul 7, 2026

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
07:48

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

Peeking into the black box: new biomarkers for acute kidney injury

J M Thurman1, C R Parikh

  • 1Department of Medicine, Division of Nephrology and Hypertension, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA. Joshua.thurman@uchsc.edu

Kidney International
|February 1, 2008
PubMed

Insights

Elevated liver fatty acid-binding protein (L-FABP) shows promise in predicting acute kidney injury (AKI) in pediatric cardiac surgery patients. Further validation is needed for these novel biomarkers to ensure clinical utility in diagnosing AKI.

Area of Science:

  • Nephrology
  • Biomarker Discovery
  • Pediatric Cardiology

Background:

  • Acute kidney injury (AKI) diagnosis is challenged by delayed detection and varied definitions.
  • Effective AKI therapies are limited by diagnostic and prognostic uncertainties.
  • Novel biomarkers are crucial for improving AKI diagnosis and patient outcomes.

Purpose of the Study:

  • To investigate the predictive value of liver fatty acid-binding protein (L-FABP) for AKI in children undergoing cardiac surgery.
  • To assess the potential of L-FABP as an early diagnostic marker for AKI.
  • To highlight the need for rigorous validation of new AKI biomarkers.

Main Methods:

  • Study by Portilla et al. focused on pediatric patients undergoing cardiac surgery.
  • Measured elevations in liver fatty acid-binding protein (L-FABP) levels.
  • Correlated L-FABP levels with the incidence of AKI.

Main Results:

  • Elevated L-FABP levels were found to predict AKI in the studied cohort.
  • L-FABP demonstrates potential as a predictive biomarker for AKI.
  • The findings suggest L-FABP's utility in early AKI detection in this population.

Conclusions:

  • Liver fatty acid-binding protein (L-FABP) may serve as a valuable predictive biomarker for acute kidney injury (AKI) in pediatric cardiac surgery.
  • Early identification of AKI through biomarkers like L-FABP can facilitate timely intervention.
  • Rigorous validation in diverse patient cohorts is essential before clinical adoption of new biomarkers for AKI.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...